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The cytotoxicity of doxorubicin is strongly influenced by variation
in extracellular pH (Born and Eichholtz-Wirth, 1981). As is the
case with other weak electrolytes (Brophy and Sladek, 1983;
Dennis et al, 1985; Mikkelsen et al, 1985; Skovsgaard, 1977), this
variation in toxicity may be due to a pH-dependent shift in the
ratio of the ionized to non-ionized form of this weak base. In its
non-ionized form, the lipophilicity of weak electrolytes is
increased, thereby enhancing their diffusion through the cell
membrane to an intracellular site of action. Extensive investiga-
tion of the mechanism of doxorubicin uptake indicates that passive
diffusion of the non-ionized form of the drug is the most likely
explanation for the pH-dependent modification of cellular drug
uptake (and by implication, cytotoxicity), but that carrier-mediated
uptake cannot be excluded with the specificity or efficiency of the
carrier being dependent on the ionization status of the drug
(Skovsgaard, 1977). The toxicity of a number of drugs is sensitive
to variation in pH by various mechanisms which are not dependent
on ionization-dependent diffusion through the cell membrane
(Jähde et al, 1989; Skarsgard et al, 1995). For example, extracel-
lular pH variation substantially modifies the toxicity but not the
cellular uptake and accumulation of the actively transported drug
melphalan (Skarsgard et al, 1995). Additionally, it has been
reported that the cytotoxicity of free doxorubicin is identical to
doxorubicin bound to large particles excluded by the cell (Tritton
and Yee, 1982). These results suggest an extracellular (membrane)
site of doxorubicin action, i.e. with toxicity not being dependent
on drug uptake.
To the extent toxicity is dependent upon the intracellular accu-
mulation of doxorubicin, variation in pH and its resultant effect on
drug charge and membrane diffusion would affect the drug’s intra-
cellular concentration and therefore its toxicity (Eichholtz-Wirth,
1980). In theory, at steady state, the intravesicular concentration of
a weak electrolyte which is impermeable in its charged form, but
membrane permeable in its uncharged form, is dependent upon the
magnitude of the pH gradient across the cell membrane and the
drug pKa (Roos and Boron, 1981). This has important implications
for the differential uptake and potentially the toxicity of weak
electrolytes, such as doxorubicin, in tumour and normal tissue.
Although the intracellular pH of tumour and normal tissue is
similar, the extracellular pH of human tumours is more acidic than
normal tissues, giving rise to substantially different cellular pH
gradients in these tissues (Vaupel et al, 1989; Gerweck and
Seetharaman, 1996).
To evaluate the role of extracellular and intracellular pH and the
pH gradient on doxorubicin accumulation and cytotoxicity, studies
were conducted on normal and low-pH-adapted Chinese hamster
ovary cells in vitro. As previously described, low-pH-adapted cells
are resistant to changes in intracellular pH upon reduction of extra-
cellular pH (Kozin and Gerweck, 1998). Therefore, at a particular
extracellular pH, different pH gradients are obtained in the two
cell types, whereas at a similar intracellular pH the extracellular
pH substantially differs.
MATERIALS AND METHODS
Cell culture
Chinese hamster ovary cells were cultured and studied in Ham’s
F-12 medium supplemented with 12% fetal bovine serum plus
antibiotics. The medium was buffered with 15 mM Hepes, 10 mM
EPPS, plus approximately 3 mM sodium bicarbonate from the
serum. Medium pH was adjusted with 1 N hydrochloric acid or 1 N
sodium hydroxide at 37°C. Cells were grown as subconfluent
monolayers and transferred twice per week. Normal cells were
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cultured in medium adjusted to pH 7.4, and acid-adapted cells
continuously cultured (> 2 months) in medium adjusted to pH 6.8.
During culture, the pH of the medium decreased by approximately
0.2 pH units over 3–4 days in both cell types. The doubling times
of the normal and acid-adapted cells were similar, i.e. 13–14 and
14–15 h respectively. All experimental studies were performed on
exponentially growing cells.
Measurement of intracellular pH
Intracellular pH was evaluated by the method originally developed
by Waddell and Butler (1959), which is based on the equilibrium
distribution of the weak acid [14C]DMO ([2-14C]5,5-dimethyl-2,4-
oxazolidinedione) across the cell membrane. This technique, with
some modification, has frequently been used by others and is
described in detail elsewhere (Chu and Dewey, 1988; Fellenz and
Gerweck, 1988; Kozin and Gerweck, 1998). Briefly, trypsinized
cell suspensions (5–10 ´ 105 cells ml–1) were concurrently labelled
with [3H]water and [14C]DMO or [14C]inulin. Twenty to thirty
minutes after the adjustment of the extracellular pH (pHe), samples
of the suspension were centrifuged through 0.2 ml of silicone oil
into 0.06 ml of 0.8 M perchloric acid. Aliquots of the supernatant
and perchloric acid cell extracts were removed for determination
of total and extracellular water and intracellular and extracellular
DMO. These data were used to calculate intracellular pH (pHi) at
various pHe (Kozin and Gerweck, 1998).
Measurement of cellular doxorubicin
Cell suspensions (5–10 ´ 106 cells ml–1) were prepared in medium
at the appropriate pH, brought to 37°C and spiked with doxorubicin
(doxorubicin hydrochloride VHA, Irving, TX, USA) also prepared
in pH-adjusted medium to yield a final concentration of 10 mg ml–1.
The suspension was continuously agitated with a reciprocal shaker,
and 1-ml samples were periodically removed for up to 100 min.
The sample was layered on the top of a two-phase combination of
silver nitrate (5.5%, 100 ml, lower phase) (Schwartz, 1973) and sili-
cone oil (200 ml, upper phase) in a polypropylene microcentrifuge
tube, and immediately centrifuged. The upper medium layer was
sampled for measurement of extracellular doxorubicin. The pellet
was resuspended in the silver nitrate solution and extracted for
30 min at 0°C. The silver nitrate extract and medium were further
extracted with chloroform/methanol (9:1), dried over nitrogen, and
dissolved in 100 ml formate buffer (0.1% ammonium formate,
pH 4.0) for high-performance liquid chromatography (HPLC)
analysis (Israel et al, 1978). Samples (35–75 ml) were separated on
a 150 ´ 0.9 mm i.d. column containing a C18 5-mm silica particle
stationary phase and a mobile phase of 0.1% ammonium formate,
pH 4, and acetonitrile (3:1), at a flow rate of 0.6 ml min–1.
Doxorubicin was quantitated by area under the curve absorbance at
479 nm compared with known concentrations of doxorubicin.
Doxorubicin metabolites were not detected. The HPLC measure-
ments yielded the total extracted cellular concentration of doxoru-
bicin and the adhering fluid layer surrounding the cells. The size of
the extracellular compartment was determined by analysis of the
fraction of total water per cell ([3H]water) and extracellular water
([14C]inulin). After adjusting for doxorubicin contained in the
adherent extracellular water space, the doxorubicin concentration
per unit cell water was calculated.
Evaluation of drug cytotoxicity
Doxorubicin was freshly diluted in medium at the appropriate pH
before use and added to single cell suspensions (2 ´ 105 cells ml–1)
at pH 7.4, 6.8 or 6.4 (± 0.05). Cells were incubated for 90 min at
37°C with gentle continuous agitation on a reciprocal shaker.
After drug treatment, the cells were centrifuged, washed twice
with drug-free medium and seeded in 25 cm2 plastic flasks to yield
50–200 colonies. Four to six flasks were used for each data point.
Medium at pH 7.4 was used for washing and cloning of normal
cells, and pH 6.8 medium was used for acid-adapted cells. After
incubation, the colonies were stained and counted. Cell survival
was calculated as the ratio of the number of colonies divided by
the number of cells plated in treatment vs control flasks. In the
absence of drug treatment, the plating efficiency was close to
100% independent of the pHe and cell type. The drug enhance-
ment ratio (ER) was calculated as the ratio of drug doses yielding
a surviving fraction of 10% in normal cells at pHe 6.8 compared
with the drug concentration yielding the same surviving fraction
for the various other (pH and cell type) experimental conditions.
All survival curve experiments were repeated three times; normal
and low-pH-adapted cells were concurrently evaluated in each
experiment at the same extracellular pH.
Calculation of the predicted intracellular drug
concentration
The measured changes in drug cytotoxicity as a function of the pH
gradient and measured cellular concentration of doxorubicin were
compared with the predicted changes in the intracellular (cyto-
plasmic) concentration of the drug. For doxorubicin, as for a weak
base with one ionizing group, the predicted intracellular/extracel-
lular concentration ratio at equilibrium is:
Ci/Ce = (1 + 10pKa – pHi)/(1 + 10pKa – pHe),
in which Ci and Ce are the total (charged plus uncharged) intra-
cellular and extracellular drug concentrations respectively (Roos
and Boron, 1981). The pKa of doxorubicin is approximately 8.2
with remaining pKas > 9.5 (Skovsgaard, 1977).
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Figure 1 The difference between the intracellular and extracellular pH
(pHe–pHi) is plotted as a function of extracellular pH for normal and low-pH-
adapted cells. Each data point is the mean and s.d. of 12 sample assays
from three independent experiments. Intracellular pH values were
determined at 20–30 min after adjustment of extracellular pH. Confidence
intervals of extracellular pH values are ≤ 0.05 units840 LE Gerweck et al
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RESULTS
The relationship between the extracellular pH and the difference
between the intracellular and extracellular pH for normal and low-
pH-adapted cells is shown in Figure 1. At extracellular pH values
> 7.1, the magnitude of the pH gradient is similar in both cell
types, however at pH values < 7 the intracellular pH of cells
adapted to low-pH conditions is relatively resistant to extracellular
pH changes and the pH gradient difference continuously increases.
At an extracellular pH in the range of 6.0–6.4, the cellular pH
gradient in adapted cells is approximately 0.4 units greater than in
their unadapted counterparts.
Changes in the intracellular to extracellular drug concentration
ratio at pH 6.3 as a function of time after doxorubicin addition is
shown in Figure 2. In both cell types, the cellular drug concentra-
tion linearly increases with drug exposure time. Consistent with
the pH partition theory, in normal cells for which the intracellular
pH is less alkaline compared with the extracellular compartment, a
greater fraction of the weak base is ionized and therefore accumu-
lated in the intracellular compartment. A similar time-dependent
linear increase in cellular drug concentration was observed at all
extracellular pH values examined. From experiments similar to
those shown in Figure 2, the intracellular to extracellular drug
concentration ratio was determined at 90 min, i.e. identical to the
drug exposure time for the toxicity assays. The results are shown
in Figure 3. Regardless of the extracellular pH, the intracellular
doxorubicin concentration is consistently higher in normal than
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Figure 2 The measured intracellular to extracellular concentration ratio of
doxorubicin (Ci/Ce) is plotted as a function of time after doxorubicin addition.
The extracellular pH was adjusted to 6.3 approximately 30 min before drug
addition. Normal and low-pH-adapted cells were analysed concurrently. One
data point per sample from two independent experiments
Figure 4 Doxorubicin cell survival curves were measured at extracellular
pH values of 7.4, 6.8 and 6.4 (± 0.05 pH units). The means and standard
errors of three separate experiments are shown. For each experiment,
normal and low-pH-adapted cells, at the same extracellular pH, were
analysed concurrently
Figure 5 The measured and predicted intracellular to extracellular
concentration ratio of doxorubicin, and drug cytotoxicity enhancement ratio,
are plotted as a function of the difference between the intracellular and
extracellular pH (pHe–pHi). The predicted concentration ratio assumes no
drug binding or metabolism. The measured concentration ratio is for 90 min
exposure to doxorubicin. Normal cells are indicated by closed symbols; low-
pH-adapted cells by open symbols
Figure 3 The measured intracellular to extracellular concentration ratio of
doxorubicin is plotted as a function of extracellular pH. The drug
concentration ratio was measured 90 min after doxorubicin addition. The
results of independent experiments containing two or more pairs of
concurrent measurements in normal and low-pH-adapted cells are shown.
Extracellular pH values are ± 0.05 pH units
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adapted cells, although the measured magnitude of this difference
varied slightly from experiment to experiment.
The lethal response of cells to doxorubicin at extracellular pH of
values of 6.4, 6.8 and 7.4 is shown in Figure 4. For both normal
(solid curves) and low-pH-adapted cells (dashed curves), pH vari-
ation markedly influences toxicity. For example, for a 90-min
exposure to 0.5 mg ml–1 doxorubicin, the surviving fraction of
normal cells was reduced by a factor of approximately 50 at an
extracellular pH 7.4 vs 6.4. At an extracellular pH of 6.4 and 7.4,
low-pH-adapted cells were substantially more resistant to doxo-
rubicin than normal cells.
The drug cytotoxicity enhancement ratio is plotted as a function
of the difference between the intracellular and extracellular pH
(pHe – pHi) in Figure 5. Normal cells are indicated by closed circles
and adapted cells by open circles. The data for both cell types are
fitted well by a single curve, indicating that, for both cell types, the
cellular pH gradient is the determinant of variable cytotoxicity.
Two additional curves are shown in Figure 5. The lower curve
(triangles) is the expected intracellular/extracellular drug concen-
tration ratio (Ci/Ce) of doxorubicin at equilibrium if the ionized
form of the drug is membrane impermeable, the non-ionized form
is permeable and the drug is neither sequestered or metabolized.
These data are calculated from the equation above. The slope of
this curve (0.94 ± 0.12) is identical to the slope of the measured
drug enhancement ratio curve (0.95 ± 0.15).
The upper curve of Figure 5 is the measured intracellular/extra-
cellular doxorubicin concentration ratio after 90 min drug expo-
sure. As might be expected (see Discussion section), at a particular
pH gradient, the values of the measured and predicted drug
concentration ratios differ. Similar to the results observed with
drug toxicity, the data showing the relationship between the pH
gradient and measured intracellular doxorubicin concentration
both for normal and low-pH-adapted cells are fitted well by a
single curve. The slope of this curve (0.71 ± 0.20) does not signif-
icantly differ from the toxicity and predicted drug concentration
ratio curves.
DISCUSSION AND SUMMARY
The results of this study clearly show that doxorubicin accumula-
tion and toxicity increase with increasing medium pH. pH variation
may exert its drug modifying effect intracellularly, extracellularly
or via change in the cellular pH gradient. The pH-dependent effect
is clearly not related to changes in intracellular pH. For both cell
types and all pH conditions, the relationship between pHi and the
measured drug accumulation or toxicity enhancement ratio is poor
(r2 = 0.02 and 0.19 respectively). Whether pH modification of drug
uptake and toxicity is dependent upon the change in extracellular
pH or the pH gradient is less straightforward. This is because a
change in extracellular pH results in an associated change in the pH
gradient, especially in normal cells.
An analysis of the results obtained from both normal and low-
pH-adapted cells helps resolve this question. As seen in Figures 2
and 3, both the rate of accumulation and total accumulation at
90 min clearly differs in normal vs low-pH-adapted cells at the
same extracellular pH. Additionally, at a pHe of 6.4, in which the
most pronounced gradient difference between normal and low-pH-
adapted cells occurs, normal cells are substantially more sensitive
to doxorubicin than their low-pH-adapted counterparts. This indi-
cates that the pH gradient and not extracellular pH is the major
determinant of doxorubicin uptake. The relationship between the
predicted and observed results are not, however, quantitatively
precise. The measured magnitude of the gradient difference in
normal vs adapted cells is greater at pHe 6.4 > 6.8 > 7.4. At these
extracellular values, the pH gradient hypothesis predicts that
normal cells will be more sensitive (and have greater drug uptake)
than adapted cells, and this is observed. However, the measured
difference in sensitivity in normal vs adapted cells is less than the
predicted difference at a pHe of 6.8, and greater than is predicted
at a pHe of 7.4. Whether this inconsistency is due to a lack of preci-
sion in measuring the magnitude of the gradient, cytotoxicity or
other variables is unclear. However, it does not appear to be due
to changes in intrinsic properties of adapted cells because of
prolonged culture at low pH (e.g. drug membrane permeability).
It is also of note that for a particular pH gradient value (Figure
5) the measured doxorubicin accumulation (intracellular/extracel-
lular concentration ratio) is substantially greater than the predicted
ratio. This is not unexpected because doxorubicin is readily bound
and sequestered at various intracellular sites and compartments,
especially DNA and lysosomes (Noël et al, 1978; Durand, 1981),
and continually accumulates during the 90-min duration of drug
exposure. However, because the quantity of drug which accumu-
lates intracellularly is proportional to the quantity of drug which
gains access to the intracellular compartment, the numerical value
of the measured ratios would change proportionally, leaving the
slopes of the curves vs pH gradient unchanged as is observed.
To summarize, the relationship between changes in pH and the
uptake and toxicity of doxorubicin is well predicted by the pH
partition theory in normal and low-pH-adapted cells. These results
further support the suggestion that the design and utilization of
weak acid or bases with appropriate pKas may be expected to
enhance cellular uptake of available drug in tumour or normal
tissue because of the naturally occurring cellular pH gradient
differences in these tissues (Gerweck and Seetharaman, 1996;
Kozin and Gerweck, 1998).
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